KR20240108453A - 중추성 저환기와 관련된 질환을 치료하기 위한 방법 및 조성물 - Google Patents

중추성 저환기와 관련된 질환을 치료하기 위한 방법 및 조성물 Download PDF

Info

Publication number
KR20240108453A
KR20240108453A KR1020247019140A KR20247019140A KR20240108453A KR 20240108453 A KR20240108453 A KR 20240108453A KR 1020247019140 A KR1020247019140 A KR 1020247019140A KR 20247019140 A KR20247019140 A KR 20247019140A KR 20240108453 A KR20240108453 A KR 20240108453A
Authority
KR
South Korea
Prior art keywords
pharmaceutically acceptable
nri
pharmaceutical composition
acceptable salt
hypoventilation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247019140A
Other languages
English (en)
Korean (ko)
Inventor
루이지 타란토-몬테무로
데이비드 피. 화이트
로날드 파카스
로렌스 쥐. 밀러
Original Assignee
애프니메드, 인코포레이티드 (델라웨어)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 애프니메드, 인코포레이티드 (델라웨어) filed Critical 애프니메드, 인코포레이티드 (델라웨어)
Publication of KR20240108453A publication Critical patent/KR20240108453A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020247019140A 2021-11-11 2022-11-10 중추성 저환기와 관련된 질환을 치료하기 위한 방법 및 조성물 Pending KR20240108453A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163278324P 2021-11-11 2021-11-11
US63/278,324 2021-11-11
US202263305305P 2022-02-01 2022-02-01
US63/305,305 2022-02-01
PCT/US2022/049483 WO2023086433A1 (en) 2021-11-11 2022-11-10 Methods and compositions for treating conditions associated with central hypoventilation

Publications (1)

Publication Number Publication Date
KR20240108453A true KR20240108453A (ko) 2024-07-09

Family

ID=84627454

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247019140A Pending KR20240108453A (ko) 2021-11-11 2022-11-10 중추성 저환기와 관련된 질환을 치료하기 위한 방법 및 조성물

Country Status (9)

Country Link
US (1) US20250000823A1 (cg-RX-API-DMAC7.html)
EP (1) EP4429649A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024541315A (cg-RX-API-DMAC7.html)
KR (1) KR20240108453A (cg-RX-API-DMAC7.html)
AU (1) AU2022387440A1 (cg-RX-API-DMAC7.html)
CA (1) CA3237151A1 (cg-RX-API-DMAC7.html)
IL (1) IL312688A (cg-RX-API-DMAC7.html)
MX (1) MX2024005600A (cg-RX-API-DMAC7.html)
WO (1) WO2023086433A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025207125A1 (en) * 2024-03-26 2025-10-02 The Regents Of The University Of California Combination pharmacological interventions for obstructive sleep apnea

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
EP3685858A1 (en) * 2019-01-24 2020-07-29 Assistance Publique-Hopitaux De Paris A noradrenergic system stimulator in the treatment of central hypoventilation syndromes
US20220362221A1 (en) * 2019-11-04 2022-11-17 Apnimed, Inc. (Delaware) Combination pharmacological interventions for multiple mechanisms of obstructive sleep apnea

Also Published As

Publication number Publication date
US20250000823A1 (en) 2025-01-02
EP4429649A1 (en) 2024-09-18
WO2023086433A1 (en) 2023-05-19
MX2024005600A (es) 2024-05-21
JP2024541315A (ja) 2024-11-08
CA3237151A1 (en) 2023-05-19
AU2022387440A1 (en) 2024-05-23
IL312688A (en) 2024-07-01

Similar Documents

Publication Publication Date Title
US9707220B2 (en) Scopolamine for the treatment of depression and anxiety
US20110070319A1 (en) Bifeprunox doses for treating schizophrenia
US20220023316A1 (en) Methods for the treatment of depression
US20250099468A1 (en) Treating liver disorders with an ssao inhibitor
CN117177741A (zh) 用于治疗睡眠呼吸暂停的去甲肾上腺素再摄取抑制剂和大麻素的组合
JP2024541315A (ja) 中枢性低換気に関連する状態を治療するための方法および組成物
JP6181754B2 (ja) トゥレット症候群治療のための縮合ベンゾアゼピン
US20240358709A1 (en) Methods and compositions for treating sleep apnea
CN118695856A (zh) 用于治疗与中枢性通气不足相关的疾患的方法和组合物
CN117062626A (zh) 用于治疗睡眠呼吸暂停的方法和组合物
JP2024523876A (ja) 睡眠時無呼吸を治療するためのノルエピネフリン再取り込み阻害剤
WO2021202906A1 (en) Methods and compositions for treating sleep apnea
WO2025106773A1 (en) Methods and compositions for treating sleep apnea with a combination of a glp-1 agonist and a second active agent
KR20250057804A (ko) 수면 무호흡증을 치료하기 위한 방법 및 조성물
HK40112834A (en) Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions
WO2026025110A1 (en) Treatment of refractory chronic cough
WO2025162430A1 (zh) 一种药物联用及其在预防或治疗神经退行性疾病中的用途
WO2013037713A1 (en) Combinations comprising a s1p receptor modulator
HK1111604B (en) Dosage form containing oxycodone and naloxone
HK1111604A1 (en) Dosage form containing oxycodone and naloxone

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E13 Pre-grant limitation requested

Free format text: ST27 STATUS EVENT CODE: A-2-3-E10-E13-LIM-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000